AGR2 and biliary tract neoplasm: 125I can inhibit the invasion of cholangiocarcinoma by suppressing AGR2 expression and modulating related pathways [13,114], although some studies have proposed that AGR2 has limited prognostic value for cholangiocarcinoma and that AGR2 expression decreases with biliary tract cancer progression [111].